IP Verse

Pfizer patent opposition analysis

The comprehensive analysis of Pfizer opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Pfizer

Stay updated with the latest patent oppositions filed by Pfizer

Patent NumberTitleApplicantOpposition DateOpposition Company
EP3595727
Lipid Nanoparticle FormulationOREGON STATE UNIVERSITYAug 26, 2025PFIZER
EP4108671
Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses ThereofMODERNAAug 20, 2025PFIZER
EP3981437
Nucleic Acid VaccinesMODERNAJul 4, 2025PFIZER
EP4023249
Nucleic Acid VaccinesMODERNAJul 4, 2025PFIZER
EP4032979
Factor Ix Polypeptide Mutant, Its Uses And A Method For Its ProductionUNIQURE BIOPHARMAJan 31, 2025PFIZER
EP3596123
Fc-Optimized Anti-Cd25 For Tumour Specific Cell DepletionTUSK THERAPEUTICSOct 4, 2024PFIZER
EP3513802
Vector For Liver-Directed Gene Therapy Of Hemophilia And Methods And Use ThereofVRIJE UNIVERSITEIT BRUSSELAug 27, 2024PFIZER
EP3227333
Bispecific Antibodies Against Cd3Epsilon And Bcma For Use In Treatment Of DiseasesBRISTOL MYERS SQUIBBMay 16, 2024PFIZER
EP3007724
Compositions And Methods Of Immunizing Against C. DifficileSANOFI PASTEURApr 5, 2024PFIZER
EP4108769
A Method For Producing And Purifying Rna, Comprising At Least One Step Of Tangential Flow FiltrationCUREVAC REAL ESTATEFeb 29, 2024PFIZER

Top clients of Pfizer

Top companies who are the clients of Pfizer

CompanyTotal
PFIZER33